Molecular imaging and radionuclide therapy
Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis
Door Özçevik H, Öner Tamam M en Acar Tayyar MN.
Inhoud in het Engels
Abstract
Objective
To investigate the association of primary tumor volume-based parameters and immune organ (liver, spleen, bone marrow) metabolic parameters and their derived ratios [spleen-to-liver ratio (SLR), bone marrow-to-liver ratio (BLR), spleen-to-bone marrow ratio (SBR)], measured on pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT), with overall survival in gastric adenocarcinoma.